期刊文献+

玻璃体切割联合内界膜剥除术治疗顽固性糖尿病黄斑水肿 被引量:4

Observation of vitrectomy combined with internal limiting membrane peeling for refractory diabetic macular edema
下载PDF
导出
摘要 目的:观察玻璃体切割术(PPV)联合内界膜(ILM)剥除术治疗顽固性糖尿病黄斑水肿的临床疗效。方法:回顾性分析顽固性糖尿病黄斑水肿并行PPV联合ILM剥除术患者56例56眼,根据有无后极部玻璃体后脱离分为A组(无玻璃体后脱离,35例35眼)和B组(有玻璃体后脱离,21例21眼)。对比分析手术前及手术后1、3、6mo时患眼最佳矫正视力(BCVA)、黄斑中心视网膜厚度(CMT)变化情况。结果:A组手术后1、3、6mo平均CMT和BCVA与手术前比较均有差异(P<0.05)。B组手术后1、3、6mo平均BCVA与手术前比较均无差异(P>0.05);手术后1mo平均CMT与手术前比较有差异(P<0.05),术后3、6mo平均CMT与手术前比较均无差异(P>0.05)。术后1、3、6mo,两组CMT、BCVA比较均有差异(P<0.05)。结论:PPV联合ILM剥除术能有效治疗无玻璃体后脱离的顽固性糖尿病黄斑水肿,提高患者视力;但当患者玻璃体已经后脱离且没有牵拉时,PPV联合ILM剥除术治疗效果不佳。 AIM:To observe the clinical effect of vitrectomy(PPV)combined with internal limiting membrane(ILM)peeling in the treatment of refractory diabetic macular edema.METHODS:The data of 56 eyes(56 patients)with refractory diabetic macular edema accepted PPV combined with ILM peeling were collected and retrospectively analyzed.The patients were divided into Group A(no posterior vitreous detachment):35 cases(35 eyes)and Group B(with posterior vitreous detachment):21 cases(21 eyes).The best corrected visual acuity(BCVA)and central macular thickness(CMT)before and 1,3,6mo after operation were compared and analyzed.RESULTS:The mean CMT and LogMAR BCVA of Group A at 1,3 and 6mo after operation were significantly different from those before operation(P<0.05);There was no significant difference in BCVA between those before and 1,3,6mo after operation in Group B(P>0.05).The mean CMT of 1mo after operation was significantly different from that before operation(P<0.05).There was no significant difference in mean CMT between 3 and 6mo after operation and before operation(P>0.05).CMT and BCVA were significantly different between the two groups at 1,3 and 6mo postoperatively(P<0.05).CONCLUSION:PPV combined with ILM peeling can effectively treat refractory diabetic macular edema without posterior vitreous detachment,improve the patient’s vision;However,PPV combined with ILM peeling was not effective in patients without posterior vitreous detachment.
作者 张聪 许贺 徐丽 Cong Zhang;He Xu;Li Xu(Department of Ophthalmology,the Fourth People's Hospital of Shenyang, Shenyang 110031, Liaoning Province, China)
出处 《国际眼科杂志》 CAS 北大核心 2020年第12期2159-2162,共4页 International Eye Science
基金 辽宁省自然科学基金指导计划(No.2018011263-301)。
关键词 玻璃体切割 内界膜剥除 糖尿病黄斑水肿 玻璃体后脱离 vitrectomy internal limiting membrane peeling diabetic macular edema posterior vitreous detachment
  • 相关文献

参考文献3

二级参考文献20

  • 1Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. [ J ]. Ophthalmology, 1987, 94 ( 7 ) : 761-774. 被引量:1
  • 2Fong AH, Lai TY. Long-term effectiveness of ranibizumab for age- related macular degeneration and diabetic macular edema [ J ]. Clin lnterv Aging,2013,8:467 483. DOI : 10.2147/C1A. $36811. 被引量:1
  • 3Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S. : 1990-1998[J]. Diabetes Care, 2000,23(9) :1278-1283. 被引量:1
  • 4Takatsuna Y, Yamamoto S, Nakamura Y, et al. Long-term thera- peutic efficacy of the subthreshold mieropulse diode laser photoco- agulation for diabetic macular edema [ J ]. Jpn J Ophthalmol, 2011,55(4) :365-369. DOI: 10. 1007/s10384-011-0033-3. 被引量:1
  • 5Centers for Disease Control and Evention. Blindness caused by diabetes-Massachusetts, 1987-1994[ J]. JAMA, 1996, 276(23) : 1865 -1866. 被引量:1
  • 6Early Treatment Diabetic Retinopathy Study Research group. Pho- toeoagulation for diabetic maeular edema. Early Treatment Diabet- ic Retinopathy Study report number 1. [ J ]. Arch Ophthalmol, 1985,103 (12) : 1796-1806. 被引量:1
  • 7Evoy KE, Abel SR. Ranibizumab: the first vascular endothelial growth factor inhibitor approved for the treatment of diabetic macu- lar edema[J]. Ann Pharmacother, 2013,47(6) :811-818. DOI: 10. 1345/aph. 1S013. 被引量:1
  • 8Ahmadieh H,Shoeibi N, Entezari M, et al. Intravitreal bevac~zumab for prevention of early postvitrectomy hemorrhage in diabetic patients :A randomized clinical trial [J].Ophthalmology, 2009, 116 (10) : 1943-1948. DOI : 10.1016/j. ophtha. 2009.07.001. 被引量:1
  • 9Mori T, Kawara S, Shinozaki M, et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model[ J ]. J Cell Physiol, 1999,181 (1): 153-159. DOI: 10. IO02/(SICI) 1097-4652 (199910) 181:1 < 153 :AID-JCP16 >3. O. CO;2-K. 被引量:1
  • 10Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform- selective inhibitor[J]. Diabetes, 1997,46(9) :1473-1480. 被引量:1

共引文献8

同被引文献33

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部